Myasthenia Gravis (DBCOND0028961)

Identifiers

Synonyms
Myasthaenia Gravis / Myasthenia gravis / Myasthenia gravis without (acute) exacerbation / Myasthenia gravis paralytica / Myasthenia gravis (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Distigmine
A cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis.
No drug targets
Edrophonium
A cholinesterase inhibitor used to diagnose and evaluate myasthenia gravis.
Ephedrine
An alpha and beta-adrenergic agonist indicated to treat hypotension under anesthesia, allergic conditions, bronchial asthma, and nasal congestion.
Neostigmine
A cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone.
Pyridostigmine
A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants.
Zilucoplan
A complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01179893
Intravenous Immunoglobulin and Plasma Exchange in Myasthenia GravisNo drug interventionstreatment4completed
NCT02470364
Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-FNo drug interventionsNot AvailableNot Availablecompleted
NCT03979521
Burden of Disease in Myasthenia GravisNo drug interventionsNot AvailableNot Availablecompleted
NCT05408702
Exercise in Autoimmune Myasthenia Gravis and Myasthenic SyndromesNo drug interventionsNot AvailableNot Availablecompleted
NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityNo drug interventionsNot AvailableNot Availablecompleted
NCT05945784
Exploring Accessible Beauty for Individuals With Upper Extremity DeficitsNo drug interventionsNot AvailableNot Availablecompleted
NCT05917184
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia GravisNo drug interventionsNot AvailableNot Availablecompleted
NCT06381284
Feasibility of Engaging and Capturing Undiagnosed Myasthenia Gravis Participants Through a Social Media Campaign Paired With a Self-moderated AssessmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT04965987
Oxaloacetate in Myasthenia Gravistreatment1unknown_status
NCT05890833
The Risk of Falls Index for Patients With Neuromuscular DisordersNo drug interventionsNot AvailableNot Availablerecruiting
NCT00306033
Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia GravisNo drug interventionstreatment3completed
NCT06443333
National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03052751
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravistreatment2completed
NCT04674605
A Prospective Cohort Study Of Myasthenia GravisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04159805
A Study of TAK-079 in People With Generalized Myasthenia Gravistreatment2completed
NCT04158661
Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia GravisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03905161
Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk TestNo drug interventionsNot AvailableNot Availablecompleted
NCT01727193
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomytreatment3completed
NCT06259071
MuSK Myasthenia 1000 StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05979688
Yogic Breathing Exercise for People With Amyotrophic Lateral SclerosisNo drug interventionstreatmentNot Availablerecruiting
NCT04346888
A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patientstreatment2completed
NCT03059888
Trial of Orencia in Patients With Myasthenia Gravistreatment0terminated
NCT06101407
Univent Tube for Thoracoscopic Thymectomy in Myasthenic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04678115
Clinical Trial Comparing Two Non-Surgical Treatments for Severe BlepharoptosisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06502015
Biomarkers in Autoimmune Disease of Nervous SystemNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04224506
A Pilot Study to Explore the Role of Gut Flora in Myasthenia GravisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02110706
BeatMG: Phase II Trial of Rituximab In Myasthenia Gravistreatment2completed
NCT03205306
Myasthenia Gravis and PsycheNo drug interventionsNot AvailableNot Availablecompleted
NCT05564936
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisNo drug interventionsotherNot Availablerecruiting
NCT02902536
Tissue Repository for Studies of Myasthenia GravisNo drug interventionsNot AvailableNot Availablecompleted
NCT00987116
Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravistreatment4completed
NCT04590716
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and FlaresNo drug interventionsNot AvailableNot Availablecompleted
NCT00294658
Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapytreatment3completed
NCT01469858
Perception and Multisensory Integration in Neurological Patients Using fMRINo drug interventionsbasic_scienceNot Availableunknown_status
NCT04951622
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravistreatment3recruiting
NCT02609022
Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravistreatment1 / 2completed
NCT05828225
Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia GravisNo drug interventionstreatment1recruiting
NCT04837625
Study of Myasthenic Crisis in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05992025
Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia GravisNo drug interventionstreatmentNot Availablerecruiting
NCT04728425
Subcutaneous Immunoglobulin for Myasthenia Gravistreatment2recruiting
NCT06277830
Physical Activity Monitoring in Myasthenia GravisNo drug interventionsNot AvailableNot Availablerecruiting
NCT06299748
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.Not AvailableNot Availablerecruiting
NCT05045248
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravistreatment2completed
NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03759366
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)treatment3completed
NCT04768465
Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia GravisNot AvailableNot Availablerecruiting
NCT00004682
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia GravisNo drug interventionstreatmentNot Availableterminated
NCT05230082
Acupuncture in Myasthenia Gravis (AcuMG)No drug interventionstreatmentNot Availablecompleted
NCT03905473
Physical Activity and Fatigue in Myasthenia GravisNo drug interventionsNot AvailableNot Availablecompleted
NCT04524273
Myasthenia Gravis Inebilizumab Trialtreatment3active_not_recruiting
NCT05265273
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravistreatment2 / 3recruiting
NCT05324176
Diaphragm Thickness by Ultrasonography in Neurological DisordersNo drug interventionsscreeningNot Availablecompleted
NCT06501794
Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT02102594
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)treatment2terminated
NCT00727194
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravistreatment2terminated
NCT00774462
Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravistreatment2completed
NCT01927692
Therapeutic Plasma Exchange in MGNo drug interventionsNot AvailableNot Availablecompleted
NCT01102192
The Role of the Thymus in Myasthenia GravisNo drug interventionsNot AvailableNot Availablecompleted
NCT06371040
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia GravisNo drug interventionstreatment1recruiting
NCT03743740
The Effect of Spinal Stabilization Exercises in Patients With Myasthenia GravisNo drug interventionstreatmentNot Availablecompleted
NCT05455840
A Prospective, Single-Center Investigation of the da Vinci SPĀ® Surgical System in Anterior Mediastinal DiseaseNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06221501
Perioperative Efgartigimod for Thymoma and Myasthenia GravisNo drug interventionstreatment2not_yet_recruiting
NCT03818204
Clinical Trial to Improve the Magnetic Levator ProsthesisNo drug interventionstreatmentNot Availablecompleted
NCT03613272
The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of SternumNo drug interventionstreatmentNot Availableunknown_status
NCT06539169
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00997412
Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia GravisNo drug interventionstreatmentNot Availableunknown_status
NCT05150210
SP Thoracic IDE StudyNo drug interventionsotherNot Availableactive_not_recruiting
NCT05332210
Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia GravisNo drug interventionstreatment3recruiting
NCT01105923
Study of an Intervention to Improve Problem List Accuracy and UseNo drug interventionsdiagnosticNot Availableunknown_status
NCT06491238
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia GravisNo drug interventionstreatmentNot Availablerecruiting
NCT06249438
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyNo drug interventionstreatment1recruiting
NCT04535843
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05095103
Immune Profiles in Myasthenia GravisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05039190
Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG PatientsNo drug interventionstreatment3completed
NCT05566964
Descriptive Analysis of Real-world Data Collected With ME&MGopenNo drug interventionsNot AvailableNot Availablerecruiting
NCT06241521
Myasthenia Gravis Registry in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04695379
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT06414954
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia GravisNo drug interventionstreatment2recruiting
NCT05301153
Interleukin and Autoantibodies in Myasthenia Gravis.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06002945
Exploring Outcomes and Characteristics of Myasthenia Gravis 2No drug interventionsNot AvailableNot Availablerecruiting
NCT02118805
Innovative Measures of Speech and Swallowing Dysfunction in Neurological DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT06064461
Vitaccess Real MG RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01047761
Exercise for Stable Myasthenia GravisNo drug interventionstreatment1unknown_status
NCT04176211
The Impact of Myasthenia Gravis in the Real WorldNo drug interventionsNot AvailableNot Availablecompleted
NCT01325571
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisNo drug interventionstreatment3completed
NCT04101578
Clinical Prognosis and Progression of Myasthenia Gravis PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00309088
FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) PatientsNo drug interventionstreatment3completed
NCT05919407
Pyridostigmine and Amifampridine for Myasthenia GravisNo drug interventionstreatment3recruiting
NCT02761707
Biomarkers in Neural DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT03826056
Neurology Inpatient Clinical Education TrialNo drug interventionshealth_services_researchNot Availablecompleted
NCT03900585
Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis PatientsNo drug interventionstreatmentNot Availablewithdrawn
NCT06158815
Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia GravisNo drug interventionstreatmentNot Availablerecruiting
NCT06006832
A Prospective Cohort Study of Myasthenia Gravis in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03792659
The EXPLORE MG Registry for Myasthenia GravisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04541875
Medication Adherence and Non-adherence in Adults With Rare DiseaseNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04226170
Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia GravisNo drug interventionstreatment2recruiting
NCT02066519
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia GravisNo drug interventionstreatmentNot Availablecompleted
NCT05694234
Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02317224
The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal TumorNo drug interventionstreatment2recruiting
NCT05218096
Study of ALXN2050 in Adult Participants With Generalized Myasthenia GravisNo drug interventionstreatment2terminated
NCT05888558
Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia GravisNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02774239
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)No drug interventionstreatment3completed
NCT06441825
Patient Observation With Environmental and Wearable Sensors in Myasthenia GravisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04561557
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemNo drug interventionstreatment0recruiting
NCT00704626
Serum Auto-Antibodies in Neurological DiseasesNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00716066
Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesNo drug interventionstreatment2active_not_recruiting
NCT06298565
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod AlfaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02473965
Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia GravisNo drug interventionstreatment2completed
NCT03597373
Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia GravisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02965573
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle WeaknessNo drug interventionstreatment2completed
NCT01828294
Subcutaneous Ig Maintenance Therapy for Myasthenia GravisNo drug interventionstreatment1terminated
NCT05337891
Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia GravisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01555580
A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia GravisNo drug interventionstreatment0unknown_status
NCT03863080
A Study of RVT-1401 in Myasthenia Gravis (MG) PatientsNo drug interventionstreatment2completed
NCT01268280
Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia GravisNo drug interventionstreatment2terminated
NCT00424489
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisNo drug interventionstreatment1terminated
NCT06193889
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia GravisNo drug interventionstreatment2not_yet_recruiting
NCT00309101
An Open Study for Steroid Resistant, Non-Thymectomized MG PatientsNo drug interventionstreatment3completed
NCT06106672
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia GravisNo drug interventionstreatment1 / 2recruiting
NCT06256172
Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and HypertensionNo drug interventionspreventionNot Availablecompleted
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordNo drug interventionsNot AvailableNot Availablerecruiting
NCT02100969
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia GravisNo drug interventionstreatment2completed
NCT05132569
Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia GravisNo drug interventionstreatment3terminated
NCT03510546
Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia GravisNo drug interventionstreatment4unknown_status
NCT05214612
Predictors and Prognostic Factors of Myasthenia Gravis OutcomeNo drug interventionsNot AvailableNot Availablerecruiting
NCT00285350
Mycophenolate Mofetil in Myasthenia GravisNo drug interventionstreatment3completed
NCT03914638
Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia GravisNo drug interventionstreatment2 / 3unknown_status
NCT00814138
Efficacy of Methotrexate in Myasthenia GravisNo drug interventionstreatment2completed
NCT01480596
The Evaluation of Belimumab in Myasthenia Gravis (MG)treatment2completed